Tag: Ablative Solutions
Ablative Solutions publishes data from the Peregrine post-market study
Ablative Solutions has revealed that positive six-month results from the Peregrine post-market s...
TARGET BP I trial enrols its first patient
The first patient has been randomised in the TARGET BP I trial at the Piedmont Heart Institute i...
CRT 2019: Peregrine catheter demonstrated 100% procedural success in post-market clinical trial
The Peregrine system infusion catheter (Ablative Solutions) has demonstrated 100% procedural suc...
Unique therapeutic approach to treating uncontrolled hypertension receives US$77 million financing
Ablative Solutions has announced the first close of its US$77 million Series D funding round. The ro...
